The role of interleukin-17 in inflammation-related cancers

The role of interleukin-17 in inflammation-related cancers

Emerging evidence indicates a correlation between inflammation and the development and progression of cancer. Among the various inflammatory signals, interleukin-17 (IL-17) family cytokines serve as a critical link between inflammation and cancer. IL-17 is a highly versatile pro-inflammatory cytokin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xingru Zhang, Bangjie Li, Tian Lan, Conner Chiari, Xiaoyang Ye, Kepeng Wang, Ju Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	interleukin-17 cancer inflammation tumor microenvironment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1479505/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Salivary Levels of Interleukin-17 in Iranian Patients With Systemic Sclerosis
by: Ali Tadayon, et al.
Published: (2024-12-01)

Interleukin-17 prevents oxidative stress from damaging osteoblast formation by inhibiting autophagic degradation of metallothionein-2
by: Xueyan Ling, et al.
Published: (2024-06-01)

The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A
by: J. A. Mogulevtseva, et al.
Published: (2018-07-01)

Restoration of Type 17 immune signaling is not sufficient for protection during influenza-associated pulmonary aspergillosis
by: Aijaz Ahmad, et al.
Published: (2025-01-01)

Current concepts in the pathogenesis of spondyloarthritis
by: Nibha Jain, et al.
Published: (2020-01-01)

Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
by: Meifang Li, et al.
Published: (2025-02-01)

Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
by: Jingfang Wang, et al.
Published: (2025-02-01)

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)

Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis
by: Jie Yang, et al.
Published: (2025-01-01)

Editorial: LncRNAs in tumor microenvironment: its role in immunoregulation and inflammation
by: Dipanjan Ghosh
Published: (2025-02-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers
by: Ruyi Liu, et al.
Published: (2025-02-01)

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01)

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
by: Said SS, et al.
Published: (2025-01-01)

Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma
by: Zhong L, et al.
Published: (2025-01-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis
by: Meng Hsuan Kuo, et al.
Published: (2024-12-01)

Serum interleukin-6, interleukin-8, and interleukin-1 receptor antagonist levels in South Indian fibromyalgia patients and its correlation with disease severity
by: Sandeep Surendran, et al.
Published: (2021-01-01)

The role of interleukin-6 classic and trans-signaling and interleukin-11 classic signaling in gastric cancer cells
by: Josephine Runge, et al.
Published: (2024-08-01)

Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer
by: Siyu Xiang, et al.
Published: (2025-01-01)

Immune regulatory genes impact the hot/cold tumor microenvironment, affecting cancer treatment and patient outcomes
by: Mengmeng Sang, et al.
Published: (2025-01-01)

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
by: Cheng Xu, et al.
Published: (2023-04-01)

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors
by: Alejandro Diaz-Barreiro, et al.
Published: (2025-01-01)

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01)

Blood levels of cytokines highlight the role of inflammation in Alzheimer's disease
by: Lorenzo Campanelli, et al.
Published: (2025-01-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)

Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils
by: E. Jablonska, et al.
Published: (2003-01-01)

“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
by: Barbara Seliger
Published: (2024-11-01)

Exploring PANoptosis in head and neck cancer: A novel approach to cancer therapy
by: Li Wang, et al.
Published: (2025-01-01)

Biomarkers of inflammation and colorectal cancer risk
by: Yuting Li, et al.
Published: (2025-02-01)

Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
by: Joseph M. Gaballa, et al.
Published: (2025-01-01)

Editorial: Mechanism explorations of enhancing immunotherapeutic sensitivity via mediating immune infiltration and programmed cell death in solid tumor microenvironment
by: Fang Zheng, et al.
Published: (2025-01-01)

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
by: Liubov A. Tashireva, et al.
Published: (2025-01-01)